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Background: Involvement of the inferior vena cava (IVC) by neoplasm has traditionally been considered a
contra-indication to curative surgery because of high surgical risks and poor long-term prognosis. Ad-
vances in surgical and anaesthetic techniques however have made this feasible. The aim of this study is to
evaluate the outcome of combined IVC and visceral resection in a single institution.
Methods: A retrospective review of a prospectively maintained database was performed. Pre-operative
clinicopathological data, operative details and post-operative outcomes including overall and disease-
free survival were analysed. Clinicopathological data of patients over a seven-year period undergoing
combined IVC and visceral resection was reviewed, including overall and disease-free survival.
Results: Between 2006 and 2012, 14 patients underwent IVC resection was accompanied by major
hepatectomy (8), nephrectomy (6) and multivisceral resection (3). Post resection, the IVC was recon-
structed primarily (3); with PTFE tube graft (9) or using a Gore-tex patch graft (2). All patients underwent
a R0 resection. There were two postoperative deaths within 30 days. 6 patients had postoperative
complications. There was 1 early and one late (after 6 months) IVC thrombosis. With a median follow up
of 20 months (range 5e84 months), two patients died of tumour recurrence and ten are alive with
(n ¼ 5) or without (n ¼ 5) disease.
Conclusion: Combined IVC and visceral resection can be safely performed in selected patients. Surgery
provides the possibility of negative margins, acceptable perioperative morbidity/mortality and prolonged
survival. These factors combined with lack of alternative treatments justify this approach. However,
specialist teams should perform the surgery preferably in centres with expertise in liver transplantation.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Resection of the inferior vena cava (IVC) with or without asso-
ciated visceral resection poses a signiﬁcant technical challenge.
With reﬁned surgical techniques and improved peri-operative
management however, a number of groups have reported theirer).
by Elsevier Ltd. All rights reservedresults demonstrating that this is now a feasible management op-
tion [1e4]. In patients with no viable oncological alternative,
possible beneﬁts of resection include R0 resection, acceptable
operative morbidity and prolonged survival. However, there is a
scarcity of data addressing the technical nuances, post-operative
and oncological outcome from these resections. The aim of this
study is to review the role and beneﬁt of combined multivisceral
and IVC resection in the setting of a variety of indications and to
review the pre- and intra-operative factors determining outcome..
Fig. 2. Anterior approach to the IVC in the case of a sarcoma involving the cava and
right hepatic vein.
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Data was interrogated for all patients undergoing ICV resection
along with other organ(s) from January 2006 to November 2012, at
the Department of Surgery, St. Vincent's University Hospital, Dub-
lin. Their clinicopathological and peri-operative details were
reviewed from a prospectively maintained database. The selection
criteria employed for IVC resection with or without associated
visceral resection included the exclusion of metastatic disease,
evaluation of the anatomical relationship of the lesion in relation to
hepatic veins and other organs with high-resolution computed
tomography (CT), pre-operative anaesthetic assessment including
echocardiogram and pulmonary function tests; and in the case of a
proposed combined liver resection, the absence of cirrhosis or as-
cites, platelet count 100  109/L, and a functional liver reserve
volume of greater than 25%. All potential cases were reviewed at a
multi-disciplinary team conference.2.1. Statistical analysis
Disease-free and overall survivals were assessed by
KaplaneMeier methods. Continuous variables were expressed in
median (range) and compared between subgroups when appro-
priate using the ManneWhitney U-test. Categorical variables were
compared between subgroups using the chi-squared test. A P-value
0.05 was considered to be signiﬁcant. Statistical analysis was
performed using computer software GraphPad Prism version 6.0
for Mac, GraphPad Software, La Jolla California USA (www.
graphpad.com).2.2. Operative technique
On induction, all patients were prepared for the possible use of
veno-venous bypass and also so as to avoid hypothermia. Surgical
exposure was obtained via a right subcostal incision with midline
sternal extension. An intra-operative ultrasonography was per-
formed routinely to detect any tumour invasion into the hepatic
and/or renal veins, or any additional metastatic disease not
appreciated on pre-operative imaging. The falciform ligament was
then divided and the suprahepatic inferior vena cava and hepatic
veins exposed (Fig. 1).
The surgical oncological principle of a no-touch technique was
employed where possible and all specimens were removed en bloc.
For example, in the case of an IVC leiomyosarcoma with extension
into the right hepatic vine, an anterior approach to the right hep-
atectomy was performed as described elsewhere [5] (Fig. 2).Fig. 1. Intra-operative photo representing adequate mobilisation of the retro-hepatic
and supra-hepatic IVC in the case of a leiomyosarcoma of the IVC.When employed, parenchymal transection was performed with
an ultrasonic dissector under a low central venous pressure
(<5 mmHg) achieved by intravenous ﬂuid restriction with or
without a low dose of intravenous frusemide (5e10 mg). An
intermittent Pringle manoeuver was applied when excessive
bleeding was encountered during parenchymal transection. If
clamps had to be placed above the hepatic veins on the IVC, then
complete hepatic vascular exclusionwas used. Veno-venous bypass
was indicated whenever there was a risk of tearing a major intra-
hepatic vessel, especially hepatic veins in the proximity of the IVC
or the IVC itself. Whenever possible though, hepatic vascular
exclusion with preservation of caval ﬂow was employed in order to
improve haemodynamic tolerance.
Reconstruction of the IVC depended on the extent of IVC
resection, the tumour location and extent of IVC inﬁltration. When
the IVC wall involvement was longitudinal and less than 25% of its
circumference, a tangential resection was performed and closed
with a 3/0-running prolene suture. When involvement of the IVC
wall compressionwas greater than 50% of its circumference with or
without lumen occlusion, a caval segment was resected and
replaced with a 20 mm ringed polytetraﬂuoroethylene (PTFE) graft
(Fig. 3) or a goretex patch (Fig. 4).
3. Results
Fourteen patients were identiﬁed, the mean age of which was
55.3 years (35e71) with nine females. Surgical indications includedFig. 3. PTFE tube graft placement as caval replacement following extensive resection.
Fig. 4. Post-operative CT illustrating a Dacron patch in situ following cavotomy and
resection.
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seminomatous germ cell tumour, colorectal liver metastases,
adrenocortical carcinoma, Castleman's disease, recurrent phaeo-
chromocytoma, paraganglioma, renal cell carcinoma (3) and IVC
leiomyosarcoma (3). Table 1 summarises the intra-operative and
immediate post-operative data.
Veno-venous bypass was used in 7 patients (femoral only in 5,
portal only in 1 and portal-femoral with in situ hypothermic
perfusion in 1). Peri-operative blood transfusion was required in 13
patients. In 3 cases, the IVC was amenable to primary closure as
described. 2 cases required a goretex patch and the remaining 9
required a caval segmental resection with PTFE graft replacement.
The majority of cases involving concomitant liver resection
involved a right (6) or extended right hepatectomy (3). 1 case
involved and extended left hepatectomy, and 4 cases did not
require any associated liver resection at the time of surgery. No case
required re-implantation of a remaining hepatic vein.
There were 2 in-hospital mortalities; the ﬁrst on day 17 from
multi-organ failure which manifested within 24 h of an extensive
resection including pancreaticoduodenectomy, right hemi-
colectomy, right nephrectomy and IVC resection for a recurrentTable 1
Intra-operative and immediate post-operative data.
Length of procedure (mins) 347 (250e510)
Blood loss (mls) 2690 (800e22,000)
Complications
Myocardial infarction 1
Wound infection 1
Renal failure (requiring dialysis) 1
Chylous ascites 1
Intra-abdominal collection 2
Graft thrombosis 1
Bile leak 0
30-day mortality 2phaeochromocytoma. The second, from multi-organ failure and
sepsis following a right hepatectomy and IVC resection for hepa-
tocellular carcinoma arising in a non-cirrhotic liver. There were 6
post-operative morbidities in 4 patients, all of which resolved
before discharge. No cases post-operatively satisﬁed the ISGLS
criteria for post-resection liver failure [6]. All resections were R0 on
histological examination with the IVC pathologically involved in 10
of 14.
As there is no level 1 evidence for the use of anti-coagulation
after IVC resection and/or reconstruction, this decision was left to
individual surgeon preference. Of those placed on aspirin, one
developed symptoms suggesting IVC obstructionwithin onemonth
post-operatively (bilateral lower limb oedema) and imaging
revealed a thrombosed PTFE graft. This was thrombolysed and the
patient subsequently placed on warfarin. Of those who were not
commenced on aspirin (4), one had evidence of PTFE graft partial
thrombosis at routine 6-monthly imaging, but had developed
multiple collaterals and was asymptomatic. This patient was sub-
sequently placed on aspirin only.
The median follow-up was 20 months (5e84). The 1-, 3- and 5-
year disease-free survivals in patients who survived beyond 30 days
were 75%, 33% and 33% respectively (Fig 5) and the corresponding
overall survival rates in all 14 patients were 57%, 43% and 29%
respectively. Disease recurrences (5 patients) were all extra-hepatic
and all included lung metastases. Table 2 categorises which disease
types recurred.4. Discussion
Resection of the IVC was described as far back as 1976 [7] for
isolated leiomyosarcoma, with the ﬁrst IVC resection en bloc with
liver tumour being described in 1980, in a patient with HCC,
replacing the resected IVC with a cadaveric vein [8]. However if the
literature demonstrates anything it is that this type of aggressive
surgical management is only indicated in highly selected patients,
and this in turn reﬂects the nature of the surgery and of the disease
processes that lead to possible indications for such radical surgery.
All patients in this cohort went through a multi-disciplinary team
discussion forum following full work-up and it was only when all
other treatment options were exhausted that resection of this
magnitude was considered. For example, in the case of the0 20 40 60 80 100
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Fig. 5. Disease-free survival of the cohort of patients undergoing IVC and visceral
resection (excluding those not surviving the ﬁrst 30 days).
Table 2
Follow-up as per disease type.
Alive with no evidence of disease recurrence
Paraganglioma
Cholangiocarcinoma
Renal cell carcinoma
Castleman's disease
Non-seminomatous germ cell tumour
Alive with evidence of disease recurrence
Colorectal liver metastases
IVC Leiomyosarcoma (3)
Renal cell carcinoma
Dead with tumour recurrence
Renal cell carcinoma
Adrenocortical carcinoma
T.K. Gallagher et al. / International Journal of Surgery 12 (2014) 864e867 867hepatocellular carcinoma arising in the non-cirrhotic liver, this
lesion underwent two sessions of trans-arterial chemo-embolisa-
tion (TACE) before being considered for surgery, but did not
respond radiologically in ameaningful way, and so the decisionwas
taken to resect.
The indications for veno-venous bypass have been well-
established and most authorities would say that it be used on a
selective basis only [9]. For this particular cohort of patients the
authors see no reason that resection of the cava itself should
mandate routine use of bypass.
Histologically, despite 14 R0 resections, 4 of the 14 resections
(29%) had no histological evidence of caval involvement. This raises
questions about the optimal pre-operative assessment of the caval
involvement in these patients, as alluded to by Nuzzo et al. [10]. The
ideal method remains undeﬁned, however it is clear that if it is
technically feasible and safe to resect cava in the interests of
achieving a complete oncological clearance, then this is preferred to
leaving and R1 or even R2 clearance.
The procedure of caval and visceral resection is a formidable
challenge and should only be undertaken following a meticulous
pre-operative workup and by surgery and anaesthetic teams
experienced in liver transplant. The morbidity and mortality re-
ported in this series is not insigniﬁcant and remains a major
consideration when planning such resections, however the
achievement of a 5 year overall and disease-free survival in 33% and
29% respectively is encouraging in patients who would otherwise
have a dismal prognosis.5. Conclusion
This study demonstrates that combined IVC and visceral resec-
tion is a safe and oncologically appropriate operation for a variety of
disease processes that heretofore had few alternative approaches
and a guarded prognosis. Resectability on pre-operative imaging is
a good predictor of an R0 resection in this series. And it seems thatthe major determinant of overall and disease-free survival in those
who survive the initial insult is tumour biology.
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